Company / Total Assets
Phathom Pharmaceuticals, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$259.1M
FY2025
5-year range
$164.8M / $413.8M
FY2021-FY2025
Trend
-31.5%
vs FY2024
Sector context
#189 of 214
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s total assets of $259M is lower than 88% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 8 years, ranging from $902,000 in FY2018 to $414M in FY2023.
Based on SEC 10-K filings.
$259M in FY2025 with a 5-year CAGR of -2.6%.
Declined from $414M to $259M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +16.3%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 214This company $259.1M Sector average $7.5B
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.6%, indicating a declining trend.
- In FY2025, total assets decreased 31.5% year-over-year.
- Ranks #189 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $259.1M | -31.5% |
| FY2024 | $378.3M | -8.6% |
| FY2023 | $413.8M | +151.1% |
| FY2022 | $164.8M | -13.0% |
| FY2021 | $189.4M | -35.8% |
| FY2020 | $295.1M | +14.7% |
| FY2019 | $257.2M | +28412.0% |
| FY2018 | $902.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026